| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 125.12B | 124.29B | 124.76B | 119.82B | 122.00B | 121.93B |
| Gross Profit | 25.98B | 26.04B | 25.22B | 22.36B | 21.31B | 25.66B |
| EBITDA | 14.04B | 12.73B | 19.54B | 10.80B | 8.87B | 14.18B |
| Net Income | 11.26B | 8.10B | 10.29B | 3.66B | 2.01B | 6.17B |
Balance Sheet | ||||||
| Total Assets | 196.87B | 205.44B | 196.78B | 194.85B | 192.76B | 196.71B |
| Cash, Cash Equivalents and Short-Term Investments | 22.45B | 23.44B | 24.25B | 23.58B | 24.76B | 26.35B |
| Total Debt | 20.83B | 18.70B | 21.04B | 25.28B | 31.00B | 32.91B |
| Total Liabilities | 67.55B | 64.23B | 66.28B | 75.68B | 78.46B | 86.22B |
| Stockholders Equity | 127.00B | 138.63B | 128.01B | 116.75B | 112.06B | 108.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.46B | -1.27B | 4.48B | -2.24B | -252.00M |
| Operating Cash Flow | 0.00 | 9.04B | 4.17B | 9.02B | 3.00B | 7.58B |
| Investing Cash Flow | 0.00 | -2.06B | 1.42B | -1.45B | -2.19B | -6.64B |
| Financing Cash Flow | 0.00 | -6.74B | -7.00B | -10.21B | -3.84B | -11.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥113.67B | 8.38 | ― | 3.72% | 4.49% | 27.96% | |
73 Outperform | ¥77.09B | 9.11 | ― | 3.04% | -0.37% | -20.95% | |
71 Outperform | ¥9.45B | 7.23 | ― | 2.84% | 11.35% | -76.94% | |
69 Neutral | ¥16.70B | 9.23 | ― | 3.61% | 6.67% | 66.03% | |
65 Neutral | ¥53.35B | 19.62 | ― | 4.37% | -3.84% | -43.55% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | ¥35.55B | 20.68 | ― | 3.70% | 29.30% | -82.16% |